The AD diagnostic antibodies against Tau phosphorylation sites (AT8, AT100, AT180, PHF1, and 12E8) recognize exclusively the Sf9-Tau protein, indicating that these epitopes (outlined in Fig. 1A) are highly phosphorylated (Fig. 1F). Here, MAPT is linked to Alzheimer disease.